CLINICAL_TRIALS
trial_result
· 2021-09-01
Clinical Trial Update: Cantharidin and Occlusion in Verruca Epithelium [Phase 2]
Summary
A Phase 2 study evaluating cantharidin with occlusion for verruca vulgaris (common warts) has completed and results were posted in September 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Verrica Pharmaceuticals Inc. | Conditions: Common Wart, Warts Hand | Phase 2 | Status: COMPLETED | Results posted: 2021-09-01